HTR2C and major depressive disorder: As for the 5-HT2C receptor, studies indicate the possibility for the treatment of obesity and disorders associated with the consumption of psychostimulant drugs through the activation of this receptor, and for the treatment of anxiety, depression, and schizophrenia using 5-HT2C antagonists.